BEIJING TIANTAN BIOLOGICAL PRODUCTS CORPORATION LIMITED financial statements, including revenue, expenses, profit, and loss
The total revenue of 600161 for the last quarter is 1.21 B CNY, and it's 5.29% higher compared to the previous quarter. The net income of Q1 24 is 316.67 M CNY.